
The Randox Precision Medicine Centre provides an end-to-end pathway for pharmaceutical and biotechnology partners seeking to accelerate biomarker discovery, assay development, patient stratification and companion diagnostic programmes.
From exploratory biomarker research through to clinical validation and regulatory-ready evidence generation, our integrated services support every stage of precision medicine development.
Identify eligible patients earlier with diagnostics built around trial requirements.
Differentiate responders and refine cohorts using advanced biomarker insights and multiplex testing.
Reduce diagnostic bottlenecks through integrated assay development and validation workflows.
Generate submission-ready evidence through ISO 15189 accredited and CLIA-compliant laboratory services.
Novel Biomarkers & Custom Antibody Development
Multiplex Assay Design
Powered by FDA-approved RANCHIPĀ® technology.
Clinical & Analytical Validation
Regulatory-Ready Diagnostics
Biomarker Discovery & Validation
Multi-Omics Solutions
Companion Diagnostic Development
Powered By RANCHIP Technology
Programmes evolve as evidence emerges.
biotechGain greater precision through multiplex analysis.
android_cell_4_barClinical and regulatory confidence through validated processes.
graph_2Partner with Randox Biosciences to move from biomarker discovery to validated companion diagnostics through one connected development pathway.